54 related articles for article (PubMed ID: 24570591)
21. Is CD10 a reliable marker of invasive colorectal cancer?
Del Rio P; Crafa P; Papadia C; Benecchi L; Campanini N; Sianesi N; Montana CM; Sianesi M
Ann Ital Chir; 2011; 82(4):279-82. PubMed ID: 21834477
[TBL] [Abstract][Full Text] [Related]
22. Potential of soluble CD26 as a serum marker for colorectal cancer detection.
Cordero OJ; Imbernon M; Chiara LD; Martinez-Zorzano VS; Ayude D; de la Cadena MP; Rodriguez-Berrocal FJ
World J Clin Oncol; 2011 Jun; 2(6):245-61. PubMed ID: 21773075
[TBL] [Abstract][Full Text] [Related]
23. CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.
Gürel D; Kargı A; Karaman I; Onen A; Unlü M
Pathol Oncol Res; 2012 Apr; 18(2):153-60. PubMed ID: 21681600
[TBL] [Abstract][Full Text] [Related]
24. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer.
Maguer-Satta V; Besançon R; Bachelard-Cascales E
Stem Cells; 2011 Mar; 29(3):389-96. PubMed ID: 21425402
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia.
Sulda ML; Abbott CA; Macardle PJ; Hall RK; Kuss BJ
Cancer Biol Ther; 2010 Jul; 10(2):180-9. PubMed ID: 20534982
[TBL] [Abstract][Full Text] [Related]
27. Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.
Varona A; Blanco L; Perez I; Gil J; Irazusta J; López JI; Candenas ML; Pinto FM; Larrinaga G
BMC Cancer; 2010 May; 10():193. PubMed ID: 20459800
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects?
Stulc T; Sedo A
Diabetes Res Clin Pract; 2010 May; 88(2):125-31. PubMed ID: 20303610
[TBL] [Abstract][Full Text] [Related]
29. The dipeptidyl peptidase IV family in cancer and cell biology.
Yu DM; Yao TW; Chowdhury S; Nadvi NA; Osborne B; Church WB; McCaughan GW; Gorrell MD
FEBS J; 2010 Mar; 277(5):1126-44. PubMed ID: 20074209
[TBL] [Abstract][Full Text] [Related]
30. Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer.
Kotacková L; Baláziová E; Sedo A
Folia Biol (Praha); 2009; 55(3):77-84. PubMed ID: 19545486
[TBL] [Abstract][Full Text] [Related]
31. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
Sun YX; Pedersen EA; Shiozawa Y; Havens AM; Jung Y; Wang J; Pienta KJ; Taichman RS
Clin Exp Metastasis; 2008; 25(7):765-76. PubMed ID: 18563594
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation.
McGuinness C; Wesley UV
Front Biosci; 2008 Jan; 13():2435-43. PubMed ID: 17981724
[TBL] [Abstract][Full Text] [Related]
33. Expression of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues.
Erhuma M; Köbel M; Mustafa T; Wulfänger J; Dralle H; Hoang-Vu C; Langner J; Seliger B; Kehlen A
Int J Cancer; 2007 Jun; 120(11):2393-400. PubMed ID: 17294442
[TBL] [Abstract][Full Text] [Related]
34. Ectopeptidases in tumour biology: a review.
Carl-McGrath S; Lendeckel U; Ebert M; Röcken C
Histol Histopathol; 2006 Dec; 21(12):1339-53. PubMed ID: 16977585
[TBL] [Abstract][Full Text] [Related]
35. Methylation of neutral endopeptidase 24.11 promoter in rat hepatocellular carcinoma.
Uematsu F; Takahashi M; Yoshida M; Igarashi M; Nakae D
Cancer Sci; 2006 Jul; 97(7):611-7. PubMed ID: 16827801
[TBL] [Abstract][Full Text] [Related]
36. CD10 immunohistochemical staining in urothelial neoplasms.
Murali R; Delprado W
Am J Clin Pathol; 2005 Sep; 124(3):371-9. PubMed ID: 16191505
[TBL] [Abstract][Full Text] [Related]
37. Anti-progressive effect of neutral endopeptidase 24.11 (NEP/CD10) on cervical carcinoma in vitro and in vivo.
Terauchi M; Kajiyama H; Shibata K; Ino K; Mizutani S; Kikkawa F
Oncology; 2005; 69(1):52-62. PubMed ID: 16103735
[TBL] [Abstract][Full Text] [Related]
38. Involvement of neutral endopeptidase in neoplastic progression.
Sumitomo M; Shen R; Nanus DM
Biochim Biophys Acta; 2005 Aug; 1751(1):52-9. PubMed ID: 16054017
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade.
Kajiyama H; Kikkawa F; Ino K; Shibata K; Mizutani S
Adv Exp Med Biol; 2003; 524():245-8. PubMed ID: 12675245
[No Abstract] [Full Text] [Related]
40. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
